| Combined (N = 624) | Male (N = 182) | Female (N = 442) | p-valuese |
---|---|---|---|---|
Mean or N | Mean or N | Mean or N | ||
Adipokines | ||||
 Adiponectin (ug/mL) | 26.3 (21.5) | 19.5 (18.3) | 29.1 (22.1) | < 0.001 |
 Leptin (ng/mL) | 21.9 (15.3) | 11.0 (10.3) | 26.4 (14.8) | < 0.001 |
 Resistin (ng/mL) | 34.5 (16.5) | 35.0 (17.5) | 34.3 (16.1) | 0.661 |
 Leptin-adiponectin ratio (LAR) | 1.24 (1.15) | 0.82 (0.87) | 1.41 (1.21) | < 0.001 |
 Adiponectin-Resitin Index (ARI) | 1.18 (0.31) | 1.31 (0.30) | 1.12 (0.29) | < 0.001 |
cIMT | ||||
 Average cIMT (mm) | 0.67 (0.15) | 0.71 (0.19) | 0.66 (0.14) | 0.003 |
Potential confounders | ||||
 Age (years) | 50.2 (14.4) | 48.6 (15.7) | 50.8 (13.7) | 0.097 |
 BMI (kg/m2) | 30.7 (6.03) | 30.2 (5.94) | 30.9 (6.05) | 0.174 |
 Life time smoking > 100 cigarettes (N, %) | 182 (29.2%) | 99 (54.4%) | 83 (18.8%) | < 0.001 |
Cytokines | ||||
 InterLeukin-6 (pg/mL) | 4.91 (6.77) | 4.55 (5.25) | 5.06 (7.31) | 0.331 |
 InterLeukin-1 Beta (pg/mL) | 1.83 (6.55) | 1.20 (1.26) | 2.08 (7.73) | 0.02 |
 InterLeukin-8 (pg/mL) | 9.14 (8.70) | 9.69 (7.91) | 8.91 (9.00) | 0.284 |
 Tumor Necrosis Factor alpha (pg/mL) | 5.27 (3.58) | 5.49 (3.65) | 5.17 (3.55) | 0.311 |
Metabolic profile | ||||
 Normal glucose tolerance (yes) (N, %)a | 215 (34.5%) | 56 (30.8%) | 159 (36.0%) | 0.25 |
 Normal blood pressure (N, %)b | 342 (54.8%) | 86 (47.3%) | 256 (57.9%) | 0.019 |
 Normal lipid level (N, %)c | 239 (38.3%) | 87 (47.8%) | 152 (34.4%) | 0.002 |
Medications | ||||
 T2D Medication (yes) (N, %) | 123 (19.7%) | 26 (14.3%) | 97 (21.9%) | 0.038 |
 Hypertension medication (yes) (N, %) | 195 (31.3%) | 55 (30.2%) | 140 (31.7%) | 0.794 |
 Lipid lowering medication (yes) (N, %) | 172 (27.6%) | 47 (25.8%) | 125 (28.3%) | 0.599 |
Metabolic health | ||||
 Metabolically elevated riskd (yes) (N, %) | 507 (81.3%) | 146 (80.2%) | 361 (81.7%) | 0.756 |